Don’t Miss 'The Provider’s Approach to PCSK9 Antibodies' CME/CE Dinner Symposium

In order to bring further insight and understanding surrounding PCSK9 antibodies and their use in clinical practice, the NLA will host an in-depth supplemental symposium to be held in conjunction with the NLA 2016 Fall Clinical Lipid Update. This 2-hour symposium, held Friday, August 26 from 6:45–9:00 p.m., will present the latest data and usage guidelines surrounding this new class of lipid-lowering therapies. Earn CME/CE credits while gaining practice-based knowledge on the necessity of LDL thresholds in therapy utilization, the limits to LDL-lowering, and treating patients with statin intolerance and genetic dyslipidemias.

The symposium is designed for clinical lipidologists, cardiologists, endocrinologists, primary care physicians, physician assistants, pharmacists, advanced practice nurses, and other healthcare professionals involved in the care of patients with elevated cholesterol levels.  

For more information on this symposium, visit lipid.org/pcsk9sympo.